Progress of immunotherapy in chronic lymphocytic leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 380-384, 2021.
Article
em Zh
| WPRIM
| ID: wpr-907187
Biblioteca responsável:
WPRO
ABSTRACT
Chronic lymphocytic leukemia (CLL) is a heterogeneous, mature B-cell clonal malignancy that mainly affects the senior. The immunotherapies such as chimeric antigen receptor T cell therapy, bi/tri-specific cell binding agent, immune check point therapy, etc., pave several new avenues for CLL treatment, especially the combined applications of new and existing therapies have shown improved efficacy and safety. This article attempts to review the immunotherapies and their combinatorial applications in CLL.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2021
Tipo de documento:
Article